F. Jamali

871 total citations
22 papers, 705 citations indexed

About

F. Jamali is a scholar working on Pharmacology, Oncology and Spectroscopy. According to data from OpenAlex, F. Jamali has authored 22 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 7 papers in Oncology and 5 papers in Spectroscopy. Recurrent topics in F. Jamali's work include Inflammatory mediators and NSAID effects (11 papers), Analytical Chemistry and Chromatography (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). F. Jamali is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Analytical Chemistry and Chromatography (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). F. Jamali collaborates with scholars based in Canada, Ireland and Iran. F. Jamali's co-authors include Dion R. Brocks, Micheline Piquette‐Miller, Anthony S. Russell, Robert T. Foster, Saeed Sattari, Brian W. Berry, Subrata Ghosh, George R. Gunn, Bernd Meibohm and Ganesh M. Shankar and has published in prestigious journals such as British Journal of Pharmacology, Clinical Chemistry and Pharmaceutical Research.

In The Last Decade

F. Jamali

22 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Jamali Canada 16 272 206 165 148 117 22 705
S. K. Paulson United States 11 411 1.5× 76 0.4× 113 0.7× 62 0.4× 144 1.2× 18 752
Poe‐Hirr Hsyu United States 16 77 0.3× 151 0.7× 230 1.4× 59 0.4× 222 1.9× 32 892
Suk Han Wan United States 14 125 0.5× 117 0.6× 143 0.9× 77 0.5× 125 1.1× 22 819
Ragini Vuppugalla United States 16 90 0.3× 458 2.2× 304 1.8× 116 0.8× 214 1.8× 27 898
W J Jusko United States 14 99 0.4× 166 0.8× 102 0.6× 37 0.3× 194 1.7× 29 773
Punit H. Marathe United States 15 81 0.3× 158 0.8× 220 1.3× 44 0.3× 246 2.1× 31 854
J Kneer Switzerland 15 224 0.8× 125 0.6× 109 0.7× 29 0.2× 164 1.4× 25 640
Manoranjenni Chetty United Kingdom 18 88 0.3× 217 1.1× 205 1.2× 45 0.3× 221 1.9× 41 953
Sarah Shugarts United States 9 63 0.2× 134 0.7× 259 1.6× 74 0.5× 130 1.1× 13 691
Haiyung Cheng United States 14 103 0.4× 142 0.7× 106 0.6× 100 0.7× 108 0.9× 40 738

Countries citing papers authored by F. Jamali

Since Specialization
Citations

This map shows the geographic impact of F. Jamali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Jamali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Jamali more than expected).

Fields of papers citing papers by F. Jamali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Jamali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Jamali. The network helps show where F. Jamali may publish in the future.

Co-authorship network of co-authors of F. Jamali

This figure shows the co-authorship network connecting the top 25 collaborators of F. Jamali. A scholar is included among the top collaborators of F. Jamali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Jamali. F. Jamali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Sandra, F. Jamali, P. D. Townsend, & Cleitus Antony. (2023). Adaptive neural network equalisation using skip connections for future 100 Gbit/s/λ passive optical networks. IET conference proceedings.. 2023(34). 1422–1425. 2 indexed citations
2.
Gunn, George R., et al.. (2015). From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals. Clinical & Experimental Immunology. 184(2). 137–146. 89 indexed citations
3.
Haghighatkhah, Hamidreza, et al.. (2009). SPIRAL CT FINDINGS IN COMPLICATED APPENDICITIS: PICTORIAL ESSAY. Iranian Journal of Radiology. 6(1). 1–6. 1 indexed citations
4.
Aghazadeh‐Habashi, Ali, et al.. (2006). Evaluation of glucosamine levels in commercial equine oral supplements for joints. Equine Veterinary Journal. 38(1). 93–95. 17 indexed citations
5.
6.
Jamali, F. & Saeed Sattari. (2001). High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma.. PubMed. 3(3). 312–7. 15 indexed citations
7.
Massey, K. Lorne, et al.. (1996). Acebutolol Overdose Treated with Hemodialysis and Extracorporeal Membrane Oxygenation. The Journal of Clinical Pharmacology. 36(8). 760–763. 31 indexed citations
8.
9.
Piquette‐Miller, Micheline & F. Jamali. (1995). Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.. Drug Metabolism and Disposition. 23(2). 240–245. 40 indexed citations
10.
Piquette‐Miller, Micheline & F. Jamali. (1993). Selective Effect of Adjuvant Arthritis on the Disposition of Propranolol Enantiomers in Rats Detected Using a Stereospecific HPLC Assay. Pharmaceutical Research. 10(2). 294–299. 57 indexed citations
11.
Brocks, Dion R. & F. Jamali. (1992). Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine. European Journal of Drug Metabolism and Pharmacokinetics. 17(4). 293–299. 1 indexed citations
12.
Brocks, Dion R. & F. Jamali. (1992). Clinical Pharmacokinetics of Ketorolac Tromethamine. Clinical Pharmacokinetics. 23(6). 415–427. 108 indexed citations
13.
Alessi‐Severini, Silvia, F. Jamali, F. M. Pasutto, Ronald T. Coutts, & Sajad Gulamhusein. (1990). High-Performance Liquid Chromatographic Determination of the Enantiomers of Flecainide in Human Plasma and Urine. Journal of Pharmaceutical Sciences. 79(3). 257–260. 8 indexed citations
14.
Brocks, Dion R. & F. Jamali. (1990). The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.. Drug Metabolism and Disposition. 18(4). 471–475. 30 indexed citations
15.
Skeith, Kenneth J., et al.. (1990). Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.. PubMed. 17(8). 1008–10. 35 indexed citations
16.
Foster, Robert T., F. Jamali, & Anthony S. Russell. (1989). Ketoprofen Enantiomers in Synovial Fluid. Journal of Pharmaceutical Sciences. 78(10). 881–882. 15 indexed citations
17.
Jamali, F., et al.. (1988). Longer Plasma Half-Life for Procainamide Utilizing a Very Sensitive High Performance Liquid Chromatography Assay. Therapeutic Drug Monitoring. 10(1). 91–96. 14 indexed citations
18.
Berry, Brian W. & F. Jamali. (1988). Stereospecific High-Performance Liquid Chromatographic (HPLC) Assay of Flurbiprofen in Biological Specimens. Pharmaceutical Research. 5(2). 123–125. 37 indexed citations
19.
Foster, Robert T., et al.. (1988). Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. Journal of Pharmaceutical Sciences. 77(1). 70–73. 98 indexed citations
20.
Jamali, F., et al.. (1984). High-performance liquid chromatographic analysis of tiaprofenic acid and its metabolites in plasma and urine by direct injection. Journal of Chromatography B Biomedical Sciences and Applications. 310(2). 327–333. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. K. Paulson Breakdown of academic impact, for papers by Poe‐Hirr Hsyu Breakdown of academic impact, for papers by Suk Han Wan Breakdown of academic impact, for papers by Ragini Vuppugalla Breakdown of academic impact, for papers by W J Jusko Breakdown of academic impact, for papers by Punit H. Marathe Breakdown of academic impact, for papers by J Kneer Breakdown of academic impact, for papers by Manoranjenni Chetty Breakdown of academic impact, for papers by Sarah Shugarts Breakdown of academic impact, for papers by Haiyung Cheng
Rankless by CCL
2026